Interpretation of nonfatal events after cardiac surgery: Actual versus actuarial reporting  by Grunkemeier, Gary L. & Wu, YingXing
216 The Journal of Thoracic and Cardiovascular Surgery • August 2001
CH
D
G
TS
A
CD
ET
CSP
TX
Objective:  To describe the cumulative incidence (actual) method of analysis and to
contrast it with the Kaplan-Meier method.
Method:  We use data on porcine valve replacement to illustrate these two statisti-
cal techniques. 
Results:  The “actual” analysis estimates the percentage of events expected to occur.
The percentage given by the Kaplan-Meier method is much larger.
Conclusion:  Actual (cumulative incidence) analysis is preferred for estimating the
probability of occurrence of a nonfatal time-related event.
It is not usually appreciated that the Kaplan-Meier (KM; “actuarial”)estimate of event-free percentages, when used for nonfatal time-relatedevents, gives overly pessimistic predictions. Another method, calledcumulative incidence analysis, provides the “actual” probabilities ofevent occurrences.
Survival Curves
Follow-up studies involve the collection of information regarding time-related
events, including death and nonfatal events. Instead of the usual summary statistics
(eg, mean, standard deviation), a complete description of such time-to-event vari-
ables is usually of interest. The proportion of event times that are greater than a
given time are plotted as a function of time to produce a survival (or event-free)
curve. The result is a curve starting at 100% at time zero and decreasing steadily to
0% at the longest survival time. For a completed series, when all death times are
known, the (empirical) survival curve can be readily calculated as the complement
of the cumulative sum of deaths at each point in time.
However, in ongoing studies, the investigator cannot know the complete lifetimes
of patients who are still alive at the time of the study, and survival curves must be esti-
mated before all of the patients have died. KM analysis solves this problem by assign-
ing to each person who is still alive (called a “censored” observation) a probability of
death at each future time equal to the fraction of patients who have already died at that
time. This assumes that the distribution of the times to death for currently alive
patients will follow the pattern of those who have already died. Censored patients are
added back into the calculation as future deaths distributed over future time. 
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time (cumulative incidence) has been called the “actual”
probability of SVD.
The KM method adds another step to this process, as
shown by the third (vertical) arrow in Figure 3. It considers
that both (1) patients still alive and (2) patients who have
died SVD-free are at risk for future SVD; both are “cen-
sored” in the computation. This inflates the estimate of SVD
and produces a lower SVD-free curve by including the “vir-
tual” occurrences contributed by dead patients. Figure 3
describes the result for the average (60-year-old) patient in
this series; for older patients the difference between KM and
actual estimates is even greater.
Empirical Validation
We recently provided an empirical validation of the cumu-
lative incidence method using a series of Starr-Edwards
valves implanted from 1965 through 1977 and prospective-
ly followed up through 1998, using TE as the nonfatal
event.2 This almost complete series provided an opportuni-
ty to compare the KM and actual estimates with the per-
centage of patients who really had a TE.
For the aortic series, the 30-year KM estimate of TE was
63% and the actual estimate was 34%, with only 33% of the
patients having had a TE to date. For the mitral series, the
30-year actuarial and actual TE estimates were 58% and
Nonfatal Events
The KM method is also used for events other than death, for
example, structural valve deterioration (SVD) or throm-
boembolism (TE). When applied to an event other than
death, this method includes as “censored” any patients who
have not yet experienced that event, including those who
have died and will never have the event. The resulting event-
free estimate attempts to answer the hypothetical question,
“What is the risk of the event if no patient ever died?” An
alternative method, recently called “actual” analysis in the
cardiac literature, modifies this estimate to exclude future
events attributed to already deceased patients and answers
the more direct question, “What is the risk of the event?”
Example
To illustrate these concepts, we used data from a previous
investigation of porcine valve SVD, with 4895 operative
survivors of isolated valve replacement and 29,610 valve-
years of follow-up.1 The Gompertz distribution was used to
model survival and the Weibull distribution to model SVD.
This series contained patients from the beginning of porcine
valve usage, using first-generation porcine valves and a
mean age of only 60 years. Current results would be expect-
ed to be improved, but these suffice for our expository pur-
poses.
Survival (Two-State Model)
A useful technique for describing time-related processes, in
this and more complex situations, is the multistate model.
For survival analysis, there are 2 states, alive and dead
(Figure 1). All patients begin in the alive state and make a
transition from alive to dead at varying times according to
some statistical distribution. The transition is inevitable and
final: death is called an absorbing state because once a
patient reaches that state his process is over. At any point in
time, the sum of alive plus dead is 100% and, at the end of
the process, 100% are dead. The survival curve is the plot of
the percentage alive over time that corresponds to this
process.
SVD (Three-State Model)
As an example of a nonfatal event, we used porcine valve
SVD. All valves start in the patient alive state, without SVD.
In this case, 2 absorbing states exist to terminate the valve’s
function: it can experience SVD and be explanted, or its
host can die before SVD occurs (we ignore SVD that does
not result in a terminating event). The horizontal arrows in
Figure 2 depict these 2 transitions. We would like to know
the probability of the valve ending up in each of those 2
states as a function of time. This is described by 2 curves,
which separate all valves into 3 groups at each point in time,
corresponding to the 3 states (alive, SVD, and dead) whose
total is always 100%. The percentage in the SVD state over
Figure 1. The correspondence between a Kaplan-Meier (“actuari-
al”) survival curve and a 2-state survival process. The process
begins with all patients in the alive state at time zero. As patients
die, they move from one state to the other according to a time-
related process. The percentage alive at each time is plotted by
the KM curve. At each time point the alive plus dead patients
equal 100%.
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42%, respectively, and 41% had had a TE. Thus, in both
positions, the actual estimates were much lower than the
KM estimates and only slightly higher than the percentage
of patients who had had a TE to date. Only a few additional
TEs would be expected to occur before 30 years, because
only a few patients remained at risk.
Conclusion
For event-free analysis, the cumulative incidence (actual)
method, unlike the KM method, assumes that only living
patients continue to be at risk for a future event and thus
estimates the events actually sustained. The result is that the
actual event percentages are smaller than the KM estimates,
and more so in older patients. 
The actual method provides a valid probability of failure
and is essential for individual patient counseling and popu-
lation management. For example, for management of
patients with failure-prone implanted cardiac devices, it is
the actual estimate of failure that must be weighed against
the risk of prophylactic explantation. 
Appendix: A Note on Terminology
Actuarial analysis originally referred to the life-table method,
where events are grouped into intervals.3 Since the availability of
computers, the KM method4 is used almost universally. It is called
the product-limit method because it can be considered a life-table
method in which the intervals are so small that they contain only
one event time. In this sense, it could be considered part of the
actuarial family. The essence of the 2 methods is the same—incor-
porating partially completed lifetimes by the technique of censor-
ing. In the case of survival, the censoring refers to patients still
alive. In the case of nonfatal events, censoring is done for patients
still free of the event, including deaths.
Actual analysis is a relatively new designation. Many terms
have been used in the statistical literature. Cumulative incidence is
generally preferred,5,6 but several other adjectives have been used
as well, including crude,7 unadjusted,8 absolute,9 influenced,10
and observable.11 Recently the term actual was used to refer to the
cumulative incidence method,12 and this term seems to be accept-
ed in the cardiac literature.13-18
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